Qiagen N.V.

Qiagen N.V. (FRA:QIA) Pyrosequencing-based molecular test detects and profiles genetic mutations to predict responses to EGFR inhibitor therapies in colorectal cancer patients

Qiagen N.V. (FRA:QIA) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Qiagen N.V. (FRA:QIA) Worldwide license agreement expands the Company's veterinary assay portfolio and aims to contain future outbreaks of the devastating viral disease

Qiagen N.V. (FRA:QIA) Corporate news announcement processed and transmitted by Hugin ASA. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Qiagen N.V. (FRA:QIA) Cooperation aims to better detect contaminations in dairy and other food products in China and other Asian countries

HLA-B*5701 biomarker indicates risk for severe adverse reactions to Abacavir / Experts expect more tests for similar markers in the future